Skip to content

Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction

Gait Speed for Predicting Cardiovascular Events After Myocardial Infarction

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01484158
Enrollment
450
Registered
2011-12-02
Start date
2001-10-31
Completion date
2012-12-31
Last updated
2015-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction

Keywords

Myocardial Infarction

Brief summary

There are growing evidences that gait speed is inversely associated with all causes mortality especially cardiovascular mortality among the elderly. The purpose of this study is to evaluate the predictive value of gait speed for cardiovascular events in patients after ST-segment elevation myocardial infarction (STEMI).

Detailed description

The investigators will enroll patients capable of walking with STEMI. All patients will receive successful reperfusion therapy within 12-hour from onset. Gait speed during cardiac rehabilitation is measured. Cardiovascular events were defined as a composite of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke, for an average follow-up period.

Interventions

None listed

Sponsors

Yokohama City University Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of ST-segment elevation acute myocardial infarction * Must be treated within 12 hours after symptom onset * Must be able to walk * Must receive successful primary percutaneous coronary intervention

Exclusion criteria

* History of prior myocardial infarction * Cerebrovascular disease with residual hemiplegia * Severe peripheral arterial disease

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular Events5 yearscardiovascular death, non-fatal myocardial infarction and non-fatal stroke

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026